Androgenic alopecia: A counterproductive outcome of the anabolic effect of androgens

Medical Hypotheses

Volumn 73, Issue 3, 2009, Pages 420-426

  Soni, V K ^a  

^a Reviewarticlenet   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; TESTOSTERONE;

ARTICLE; CLINICAL FEATURE; DANDRUFF; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HAIR FOLLICLE; HORMONE ACTION; HUMAN; IMPLANTATION; MALE TYPE ALOPECIA; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SCALP; SCANTY HAIR; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL; THEORY;

ALOPECIA; ANABOLIC AGENTS; ANDROGENS; HAIR; HUMANS; MODELS, BIOLOGICAL; SCALP;

EID: 67649846498     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.03.032     Document Type: Article

References (46)

1. Randall V.A. Androgens and human hair growth. Clin Endocrinol. 40 (1994) 439-457
2. Hamilton J.B. Male hormone stimulation is a prerequisite and an incitant in common baldness. Am J Anat 71 (1942) 45180
3. Hamilton J.B. Effect of castration in adolescent and young adult males upon further changes in the proportion of bare and hairy scalp. J Clin Endocrinol Metab 20 (1960) 1309-1318
4. Hamilton J.B. Male pattern hair loss in man: types and incidence. Ann NY Acad Sci 53 (1951) 708-728
5. Hunt N., and McHale S. The psychological impact of alopecia. BMJ 331 7522 (2005) 951-953
6. Fiurásková M., Kucerová R., and Kolár Z. Pathobiology of androgenetic alopecia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147 1 (2003) 37-41
7. Guyton A.C., and Hall J.E. Reproductive and hormonal function of the male (and the function of pineal gland). Textbook of medical physiology (2006), Elsevier, Philadelphia 996-1010
8. Hoffmann R., and Happle R. Current understanding of androgenetic alopecia. Part I: etiopathogenesis. Eur J Dermatol. 10 4 (2000) 319-327
9. Alfredo R. Pathogenesis of androgenetic alopecia. J Am Acad Dermatol. 50 5 (2004) 777-779
10. Caleb Santiago Hernandez B.A. Is androgenic alopecia a result of endocrine effects on the vasculature?. Med Hypotheses 62 3 (2004) 438-441
11. Hoffmann R. Male androgenetic alopecia. Clin Exp Dermatol 27 5 (2002) 373-382
12. Young J.W., Conte E.T., Leavitt M.L., Nafz M.A., and Schroeter A.L. Cutaneous immunopathology of androgenetic alopecia. J Am Osteopath Assoc 91 8 (1991) 765-771
13. Ralph M.T. Is androgenetic alopecia a photoaggravated dermatosis?. Dermatology 207 4 (2003) 343-348
14. Szasz T.S., and Robertson A.M. A theory of the pathogenesis of ordinary human baldness. Arch Dermatol Syphilol 61 (1950) 34-48
15. Klemp P., Peters K., and Hansted B. Subcutaneous blood flow in early male pattern baldness. J Invest Dermatol 92 (1989) 725-726
16. Tuncay U.E. Baldness may be caused by the weight of the scalp: gravity as a proposed mechanism for hair loss. Med Hypotheses 71 (2008) 505-514
17. Taylor P.J. Big head? Bald head! Skull expansion: alternative model for the primary mechanism of AGA. Med Hypotheses 72 1 (2009) 23-28
18. Su L.H., and Chen T.H. Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey. Arch Dermatol 143 11 (2007) 1401-1406
19. Standring S. Gray's anatomy. The anatomical basis of Clinical Practice. Face and scalp. 39th ed. (2004), Elsevier/Churchill Livingstone, New York p. 497-517
20. Damjanov I, Linder J, editors. Cell injury and cellular adaptation. In: Anderson's pathology. St. Louis (MO): Mosby Year Book Inc.; 1996. p. 357-386.
21. Warner R.R., Schwartz J.R., Boissy Y., and Dawson Jr. T.L. Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. J Am Acad Dermatol 45 6 (2001) 897-903
22. Garn S.M., Selby S., and Young R. Scalp thickness and the fat-loss theory of balding. AMA Arch Derm Syphilol 70 5 (1954) 601-608
23. Hori H., Moretti G., Rebora A., and Crovato F. The thickness of human scalp: normal and bald. J Invest Dermatol 58 6 (1972) 396-399
24. Ebling F.J. Hair follicles and associated glands as androgen targets. Clin Endocrinol Metab 15 2 (1986) 319-339
25. Imperato-McGinley J., Guerrero L., Gautier T., and Peterson R.E. Steroid 5a-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 186 (1974) 1213-1215
26. Kuttenn F., Mowszowicz I., Wright F., Baudot N., Jaffiol C., Robin M., and Mauvais J.P. Male pseudohermaphroditism: a comparative study of one patient with 5 alpha-reductase deficiency and three patients with the complete form of testicular feminization. J Clin Endocrinol Metab 49 (1979) 861-865
27. Walsh P.C., Madden J.D., Harrod M.J., Goldstein J.L., Macdonald P.C., and Wilson J.D. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. New Engl J Med 291 (1974) 944-949
28. Hibberts N.A., Howell A.E., and Randall V.A. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol. 156 1 (1998) 59-65
29. Stenn K.S., and Paus R. Controls of hair follicle cycling. J Physiol Rev 81 (2001) 449-494
30. Mecklenburg L., Tobin D.J., Müller-Röver S., Handjiski B., Wendt G., Peters E.M., et al. Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol 114 5 (2000) 909-916
31. Yano K., Brown L.F., and Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 107 4 (2001) 409-417
32. Elliott K., Stephenson T.J., and Messenger A.G. Differences in hair follicle dermal papilla volume are due to extracellular matrix volume and cell number: implications for the control of hair follicle size and androgen responses. J Invest Dermatol 113 (1999) 873-877
33. Goldman B.E., Fisher D.M., and Ringler S.L. Transcutaneous PO2 of the scalp in male pattern baldness: a new piece to the puzzle. Plast Reconstr Surg 97 6 (1996) 1109-1116 [discussion 1117 (abstract)]
34. Rushton D.H., Ramsay I.D., Norris M.J., and Gilkes J.J. Natural progression of male pattern baldness in young men. Clin Exp Dermatol 16 (1991) 188-192
35. de Lacharrière O., Deloche C., Misciali C., Piraccini B.M., Vincenzi C., Bastien P., et al. Hair diameter diversity: a clinical sign reflecting the follicle miniaturization. J Arch Dermatol 137 5 (2001 May) 641-646
36. Jackson E.A. Hair disorders. Primary Care 27 (2000) 319-332
37. Whiting D.A. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol. 28 (1993) 755-763
38. Nielsen T.L., Hagen C., Wraae K., Brixen K., Petersen P.H., Haug E., et al. Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. J Clin Endocrinol Metab 92 7 (2007) 2696-2705
39. Bienová M., Kucerová R., Fiurásková M., Hajdúch M., and Koláŕ Z. Androgenetic alopecia and current methods of treatment. Acta Dermatovenerol Alp Panonica Adriat 14 1 (2005) 5-8
40. Sinclair R. Male pattern androgenetic alopecia. BMJ 317 7162 (1998) 865-869
41. Ralph M.T. Molecular mechanisms of androgenetic alopecia. Exp Gerontol 37 8-9 (2002) 981-990
42. Whiting D.A. Male pattern hair loss: current understanding. Int J Dermatol 37 8 (1998) 561-566
43. Bensaleh H., Belgnaoui F.Z., Douira L., Berbiche L., Senouci K., and Hassam B. Skin and menopause. Ann Endocrinol (Paris) 67 6 (2006) 575-580
44. Lee A.T., and Zane L.T. Dermatologic manifestations of polycystic ovary syndrome. Am J Clin Dermatol. 8 4 (2007) 201-219
45. Tunzi M., and Gray G.R. Common skin conditions during pregnancy. Am Fam Physician. 75 2 (2007) 211-218
46. Gray H. Anatomy of human body: The fasciae and muscles of the head. Bartleby.com, Inc; 1918 [cited 2009 Feb 02]. Available from: http://www.bartleby.com/107/105.html.